블로그
-
[Philippines FDA] FDA Advisory No.2026-0622 || Public Health Warning Against the Purchase and Use of
FDA Advisory No.2026-0622 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Pepslim Bacteriostatic Water 3mL Vial” Updated: 2026-06-05 The Food and Drug Administration (FDA
blog.naver.com · 2026.06.11
-
[Philippines FDA] FDA Advisory No.2026-0623 || Public Health Warning Against the Purchase and Use of
FDA Advisory No.2026-0623 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Softgel Capsule 100’s” Updated: 2026-06-05 The Food and Drug Administration (FDA) advises the public
blog.naver.com · 2026.06.12
-
[U.S. FDA] FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable,
are currently required under federal law to register their establishments and list their products with the FDA.
blog.naver.com · 2026.06.29
-
[U.S. FDA] FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
Food and Drug Administration (FDA) today approved another over-the-counter (OTC) intranasal naloxone This action aligns with President Trump’s Great American Recovery Initiative, a federal effort to address
blog.naver.com · 2026.06.17
-
비만치료제 - 일라이 릴리 : 젭바운드(Zepbound™)
출처 : 일라이릴리(https://investor.lilly.com) 일라이 릴리는 2023년 11월 08일 (미국 동부 표준시) FDA (The U.S. Food and Drug Administration (FDA) 로 부터 2형 당뇨치료제인 마운자로 (Mounjaro)를 비만 치료제인 젭바운드(Zepbound)로 승인을 받았다.
blog.naver.com · 2023.11.09
-
Registration of Biocide Products - #2. Europe
about Europe’s way of registering biocidal products into the market and the institution that deals with Quite contrary to US’ EPA and FDA, Europe’s European Chemical Agency (ECHA) handles bioc.......
blog.naver.com · 2022.05.11
-
[FDA, 200616] 키트루다, 고형암 환자 대상 허가
pembrolizumab (KEYTRUDA, Merck & Co., Inc.) for the treatment of adult and pediatric patients with Today, the FDA a.......
blog.naver.com · 2020.06.30
-
[FDA, 200615] 제프젤카, 소세포암 허가
- 제프젤카, platinum-based 치료를 받거나 받고 병이 진행한 전이성 소세포암 환자 대상 FDA 허가 - confirmed ORR (The major efficacy outcome metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy
blog.naver.com · 2020.06.30
-
[FDA, 200610] 옵디보, 식도편평세포암종 허가
- 옵디보, 진행성 또는 전이성 식도편평세포암종, fluoropyrimidine- and pltinum-based 치료 받은 환자 대상 FDA 허가 - OS 개선 (The major the Food and Drug Administration approved nivolumab (OPDIVO, Bristol-Myers Squibb Co.) for patients with
blog.naver.com · 2020.06.14
-
[공식입점]청주 아기주사는 미소톡의원! 베네브 피부솔루션 입점!
[청주미소톡의원 홈페이지 바로가기] 수없이 많은 성장인자, 아기주사 들 중 끊임없는 연구와 최상의 제품 수준을 위한 미국 FDA 인증 제약제조시설에서의 생산공정 어느 것을 선택하시겠습니까 이제는 성장인자와 함께하는 청주미소톡 with 베네브 입니다.- 청주 미소톡의원 진료시간 - 평일 : 오전 10시.......
blog.naver.com · 2016.11.23
